Hemodynamic Effect of Nasal High-flow in Patients Suspected or Followed for a Precapillary Pulmonary Hypertension - Trial NCT06079151
Access comprehensive clinical trial information for NCT06079151 through Pure Global AI's free database. This phase not specified trial is sponsored by ADIR Association and is currently Not yet recruiting. The study focuses on Pulmonary Hypertension. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
ADIR Association
Timeline & Enrollment
N/A
Dec 01, 2023
Nov 30, 2025
Primary Outcome
Cardiac output
Summary
In this study, the investigators aim to describe the hemodynamic consequences of nasal
 high-flow measured during right heart catheterization and echocardiography. The research
 hypothesis is that nasal high-flow would increase cardiac output in patients with pulmonary
 hypertension. The concomitant echocardiography will allow to describe its sensibility to
 detect cardiovascular consequences of nasal high-flow.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06079151
Device Trial